Latest News

Alzheimer's drug associated with two-fold higher risk of hospitalization for rhabdomyolysis

A drug commonly used to manage symptoms of Alzheimer disease and other dementias — donepezil — is associated with a two-fold higher risk of hospital admission for rhabdomyolysis, a painful condition of muscle breakdown, compared with several other cholinesterase inhibitors, found a study in CMAJ.

Source link

Related posts

STAT Plus: Pharmalittle: J&J gets U.S. nod for first targeted bladder cancer drug; Allergan wins key support from advisory firms


Planet Nine: Scientists Find ‘Solid’ Evidence Of Super-Earth Planet Beyond Neptune


Medical News Today: What causes penis skin to peel?


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy